| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 75 | ₹14,325 |
| HNI / NII | 70 | 5,250 | ₹10,02,750 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | Not more than 50% of the Net Issue | — | ₹0.00 Cr |
| NII / HNI (Total) | — | Not less than 15% of the Net Issue | — | ₹0.00 Cr |
| Retail Investors | — | Not less than 35% of the Net Issue | — | ₹0.00 Cr |
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 335.94 | 230.39 | 199.91 |
| PAT | 46.45 | 27.22 | 21.73 |
| EBITDA | 47.28 | 40.69 | 34.86 |
| Net Worth | 173.11 | 131.88 | 88.96 |
| Total Assets | 426.56 | 269.24 | 213.86 |
| Reserves | 140.72 | 128.94 | 86.18 |
| Borrowings | 54.62 | 9.88 | 34.29 |
Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.
The company designs and delivers turnkey projects, including cleanroom facilities, modular systems, and customized engineering solutions.
It provides end-to-end services such as design, engineering, manufacturing, installation, and project management. With expertise in cleanroom technology, HVAC systems, and process equipment, Fabtech serves global clients, ensuring compliance with international regulatory standards.
Services:
As of July 31, 2025, the company had 185 permanent employees.
Competitive Strengths: